Description
Written by international authorities in ocular toxicology, including the Founder of The National Registry of Drug-Induced Side Effects and its current Director, this essential resource provides the clinically relevant information you need to effectively diagnose and manage herbal, chemical, and drug-related ocular problems. Comprehensive coverage of all drugs' generic and trade drug names, primary uses, ocular and systemic side effects, and clinical significance make this book - like its best-selling predecessor, Drug-Induced Ocular Side Effects - the ideal reference for quick, on-the-spot consultation.Leaders in the field provide need-to-know information on all aspects of ocular toxicology-all in one concise reference. Data from the National Registry of Drug Induced Ocular Side-Effects (Casey Eye Institute, Portland, OR) and the World Health Organization (Uppsala, Sweden) help you recognize and avoid drug-induced ocular side effects.A highly templated format makes retrieval of essential knowledge quick and easy.A wealth of full-color photographs provide vivid, visual diagnostic guidance.The latest information on approved medications helps you stay up to date and provide state-of-the-art care.Extensive coverage of principles of therapy, ocular drug delivery, methods to evaluate drug-induced visual side effects, and the role of electrophysiology and psychophysics gives you the knowledge you need to manage any challenge in ocular toxicologyAuthoritative guidance on ocular drug
Chapter
PART 2: Ocular drug delivery and toxicology
TOPICAL OCULAR ADMINISTRATION
BASIC PHARMOCOLOGY AND TOXICOLOGY OF TOPICAL MEDICATIONS
VEHICLES FOR TOPICAL OCULAR MEDICATION DELIVERY
HOW TO APPLY TOPICAL OCULAR MEDICATION
REFERENCES AND FURTHER READING
PART 3: Methods for evaluating drug-induced visual side effects
SELECTING DIAGNOSTIC TESTS
OBJECTIVE ANATOMICAL METHODS
NUMBER OF PATIENTS TO TEST
REFERENCES AND FURTHER READING
PART 4: The role of electrophysiology and psychophysics in ocular toxicology
THE ROLE OF NON-INVASIVE ELECTROPHYSIOLOGY IN DRUG TESTING
VISUAL ELECTROPHYSIOLOGY IN DRUG DEVELOPMENT
REFERENCES AND FURTHER READING
PART 5: National registry of drug-induced ocular side effects
OBJECTIVES OF THE NATIONAL REGISTRY
HOW TO REPORT A SUSPECTED REACTION
REFERENCES AND FURTHER READING
PART 6: Herbal medicines and dietary supplements– an overview
REGULATORY ISSUES AND CLASSIFICATION
REFERENCES AND FURTHER READING
PART 7: Drug-induced ocular side effects
SECTION 1: ANTI-INFECTIVES
CLASS: AIDS-RELATED AGENTS
REFERENCES AND FURTHER READING
SECTION 2: AGENTS AFFECTING THE CNS
REFERENCES AND FURTHER READING
SECTION 3: ANALGESICS, NARCOTIC ANTAGONISTS AND AGENTS USED TO TREAT ARTHRITIS
CLASS: AGENTS USED TO TREAT GOUT
REFERENCES AND FURTHER READING
SECTION 4: AGENTS USED IN ANESTHESIA
CLASS: ADJUNCTS TO ANESTHESIA
REFERENCES AND FURTHER READING
SECTION 5: GASTROINTESTINAL AGENTS
CLASS: AGENTS USED TO TREAT ACID PEPTIC DISORDERS
REFERENCES AND FURTHER READING
SECTION 6: CARDIAC, VASCULAR AND RENAL AGENTS
CLASS: AGENTS USED TO TREAT MIGRAINE
REFERENCES AND FURTHER READING
SECTION 7: HORMONES AND AGENTS AFFECTING HORMONAL MECHANISMS
CLASS: ADRENAL CORTICOSTEROIDS
REFERENCES AND FURTHER READING
SECTION 8: AGENTS AFFECTING BLOOD FORMATION AND COAGULABILITY
CLASS: AGENTS USED TO TREAT DEFICIENCY ANEMIAS
REFERENCES AND FURTHER READING
SECTION 9: HOMEOSTATIC AGENTS
CLASS: AGENTS USED TO TREAT HYPERGLYCEMIA
REFERENCES AND FURTHER READING
SECTION 10: AGENTS USED TO TREAT ALLERGIC AND NEUROMUSCULAR DISORDERS
CLASS: AGENTS USED TO TREAT MYASTHENIA GRAVIS
REFERENCES AND FURTHER READING
SECTION 11: ONCOLYTIC AGENTS
CLASS: ANTINEOPLASTIC AGENTS
REFERENCES AND FURTHER READING
SECTION 12: HEAVY METAL ANTAGONIST AND MISCELLANEOUS AGENTS
CLASS: AGENTS TO TREAT ALCOHOLISM
REFERENCES AND FURTHER READING
SECTION 13: DRUGS USED IN OPHTHALMOLOGY
CLASS: AGENTS USED TO TREAT AGE-RELATED MACULAR DEGENERATION
REFERENCES AND FURTHER READING
PART 8: Chemical-induced ocular side effects
CLASS: HERBICIDES AND INSECTICIDES
PART 9: Herbal medicine and dietary supplement induced ocular side effects
REFERENCE AND FURTHER READING
Clinical Ocular Toxicology
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
